US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 13.460
  • -1.460-9.79%
Trading Nov 12 14:43 ET
669.32MMarket Cap-4367P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mineralys Therapeutics Q3 2024 Estimates Date

Currency：USDNov 11, 2024

Estimate YoY
Revenue
0
--
EPS
-0.82
-44.74%
Analyst Rating
Strong Buy

Nov 12, 2024

Mineralys Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 11, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 11, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Mineralys Therapeutics Earnings Reports

  • Mineralys Therapeutics | 10-Q: Quarterly report

    Nov 12 22:32

  • Mineralys Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:15

  • Mineralys Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 19:12

  • Mineralys Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 19:21

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data